Page 3 - Legn News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Legn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Legn Today - Breaking & Trending Today
Legend Biotech (NASDAQ:LEGN – Free Report) had its price objective increased by Barclays from $93.00 to $94.00 in a research report report published on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Several other research firms have also weighed in on LEGN. The Goldman Sachs Group started coverage on […] ....
Legend Biotech (NASDAQ:LEGN – Free Report) had its price objective lifted by Barclays from $93.00 to $94.00 in a research note issued to investors on Wednesday, Benzinga reports. They currently have an overweight rating on the stock. A number of other research analysts also recently issued reports on the company. Scotiabank began coverage on Legend […] ....
HC Wainwright restated their buy rating on shares of Legend Biotech (NASDAQ:LEGN – Free Report) in a research report report published on Friday, Benzinga reports. HC Wainwright currently has a $87.00 price target on the stock. LEGN has been the subject of several other research reports. The Goldman Sachs Group began coverage on Legend Biotech […] ....
By Zaeem Shoaib The U.S. Food and Drug Administration is investigating certain CAR T cancer therapies based on reports that they might cause a type of white. ....
Legend Biotech (NASDAQ:LEGN – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.31) by $0.14, MarketWatch Earnings reports. The business had revenue of $96.00 million for the quarter, compared to analyst estimates of $97.25 million. The firm’s revenue was up […] ....